The Role of Oraverse (Phentolamine Mesylate) in Dental Practice
|Presenter: Dr. Sean Boynes||Release Date: 11/10/15|
|Credits: 1 CEU||Reviewed: 2023 Expiration Date: 11/10/26|
|AGD Subject Code: 340|
|CE Supporter: Septodont|
Dental patients appreciate options for reducing or eliminating the effects of local anesthetics. Previous reports signify that patients find oral numbness annoying, uncomfortable, and an alteration to quality of life. Agents for anesthetic reversal such as OraVerse can be a useful agent to improve the patient experience and overall appointment satisfaction. This CE webinar will explore OraVerse as an agent in dentistry.
Already watched the video? Login here